Aviado · Research
Longevity Daily
Tuesday, August 25, 2026
Listen
Today's Brief
Today's standout story is a long-term observational study showing metformin cut dementia incidence nearly in half — from 4.2% to 1.9% — reigniting serious debate over who should have access to this inexpensive drug. A sweeping meta-analysis of 167 vertebrate studies puts rapamycin nearly on par with caloric restriction for lifespan extension, while a 51-study review of human trials pinpoints exactly which interventions move next-generation epigenetic clocks. And if you're taking NMN or nicotinamide riboside, today's evidence-check is required reading: new findings suggest these popular supplements may shield cancer cells from chemotherapy.
10 stories6 peer-reviewed1 Aviado original
Cognitive Health & Neuroprotection
Metformin May Cut Dementia Risk in Half, Long-Term Data Shows
People who began taking metformin in the 1990s developed dementia at a rate of just 1.9%, versus 4.2% in a matched comparison group — a difference researchers described as striking given the drug's low cost and decades-long safety record. The findings suggest metformin's anti-inflammatory, metabolic, and autophagy-related mechanisms may protect the aging brain well beyond blood sugar control. This is observational data, not a randomized trial, so causation isn't confirmed — but the size and consistency of the effect are difficult to dismiss, and they add urgency to ongoing efforts to test metformin formally as a dementia preventive.
Read more →The Dementia Vaccine Some of Us Are Already Taking Without Knowing It
Researchers from the University of New Mexico plan to begin an early clinical trial of a vaccine that specifically targets toxic tau proteins — a hallmark driver of Alzheimer's — after promising results in rodents and primates. The piece also explores how existing vaccines, particularly flu and shingles shots, appear to offer unexpected cognitive protection, making a compelling case for staying current on routine immunizations. The tau vaccine is still early-stage, but the broader takeaway is that the dementia prevention pipeline is moving faster than most people realize.
Read more →More Social Activity Now Predicts Better Brain Function Years Later, Study Finds
Greater participation in social activities at baseline was associated with significantly better preservation of cognitive function over time in older adults, according to research published in Alzheimer's & Dementia. The protective effect held after controlling for baseline health, suggesting it's the engagement itself — not just the health of people who happen to stay social — driving the benefit. For readers who treat exercise as their primary cognitive health tool, this is a useful reminder that connection has its own independent protective value.
Read more →Your Brain's Language Network Stays Sharp Even as Memory Fades — MIT Study Explains Why
A new MIT study found that the brain's language network remains structurally and functionally intact in older adults, even as memory and executive function show clear signs of deterioration. The findings help explain why vocabulary and verbal fluency often hold up well into old age while other cognitive domains decline — and suggest that language-rich activities may be a worthwhile tool for brain maintenance. The study also reinforces how selectively aging targets different brain systems, pointing toward more targeted cognitive intervention strategies.
Read more →Supplements & Compounds
Popular NAD+ Supplements May Shield Cancer Cells From Chemotherapy, Study Warns
NMN and nicotinamide riboside — taken by millions for their anti-aging and cellular energy effects — may protect pancreatic cancer cells from chemotherapy, according to a newly published study. The research adds critical nuance to NAD+ precursor enthusiasm: boosting NAD+ systemically may inadvertently help cancer cells resist treatment alongside their role in supporting healthy cell renewal. Anyone currently undergoing cancer treatment or with elevated cancer risk should discuss their supplement stack with their oncologist before continuing.
Read more →Research & Papers
Rapamycin Matches Caloric Restriction for Lifespan Extension Across Species, Major Meta-Analysis Finds
After reviewing 167 studies across eight vertebrate species — from fish to monkeys — researchers found rapamycin extends lifespan almost as effectively as sustained caloric restriction, while metformin lagged significantly behind both in head-to-head comparison. The cross-species robustness of the rapamycin effect strengthens the case for human relevance, and the findings will likely accelerate interest in formal clinical trials. The drug's immunosuppressive side effects remain a real concern for routine use — but this analysis makes a compelling argument that they may be worth managing.
Read more →Only a Handful of Interventions Actually Move Next-Generation Epigenetic Clocks, 51-Study Analysis Reveals
Researchers analyzed pre- and post-intervention blood samples from 51 human longevity studies to determine which approaches reliably reduce biological age on next-generation epigenetic clocks. The clearest winners were smoking cessation, a vegan diet, metformin, and hyperbaric oxygen therapy — each moving DunedinPACE or GrimAge clocks in a meaningful direction. Many hyped interventions, including gastric bypass, failed to shift any generation-2 clock significantly, suggesting the field urgently needs better biomarker standards before declaring any protocol a success.
Read more →Aviado Research: Evaluating the Evidence Behind Today's Longevity Interventions
Aviado Research's latest analysis examines the current evidence base for popular longevity interventions, applying a structured framework to distinguish well-supported approaches from those that remain preliminary or speculative. The piece is designed to help readers cut through the noise and make more informed decisions about their own protocols.
Read the full Aviado analysis →Lifestyle & Nutrition
High Physical Activity Cuts Dementia Risk by Up to 29% — But the Type of Exercise Matters
A large study with a median 10-year follow-up found that high physical activity levels were associated with 20–29% lower risk of all-cause dementia, Alzheimer's disease, and vascular dementia specifically (relative risks of 0.80, 0.79, and 0.71, respectively). Critically, the protective effect varied substantially by activity domain, suggesting that not all movement provides equivalent brain benefit — and that the specifics of how you exercise may matter as much as how much. For readers already exercising for cardiovascular or metabolic reasons, this data adds yet another reason to be deliberate about activity type.
Read more →Chronic Inflammation Isn't an Inevitable Part of Aging — It's Largely a Lifestyle Problem
A major review by researcher Andrea Cossarizza argues that 'inflammaging' — the persistent low-grade inflammation that accompanies aging in industrialized populations — is not a biological inevitability but a modifiable consequence of diet, sedentary behavior, and environmental exposures. Data from non-industrialized populations where inflammaging is minimal is cited as key evidence that the chronic inflammation driving cardiovascular disease, neurodegeneration, and frailty is something you can meaningfully act on. Diet quality, structured exercise, sleep, and microbiome health are identified as the most tractable lifestyle levers — reframing chronic inflammation as a target, not a sentence.
Read more →